LOGIN  |  REGISTER
Amneal Pharmaceuticals
Cue Biopharma

CareCloud to Host Investor Meetings During the Week of the J.P. Morgan Healthcare Conference

January 03, 2023 | Last Trade: US$1.25 0.01 -0.79
  • Upcoming Nasdaq symbol change from MTBC to CCLD on Jan. 10

SOMERSET, N.J., Jan. 03, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: MTBC, MTBCO, MTBCP), a leader in healthcare technology solutions for medical practices and health systems nationwide, announced today that CareCloud’s president and chief executive officer, A. Hadi Chaudhry, and chief financial officer, Bill Korn, will host investor meetings on Jan. 10-11, 2023, at the same time and location as the 41st Annual J. P. Morgan Healthcare Conference in San Francisco.

As previously announced, on Tuesday, Jan. 10, 2023, CareCloud will change its Nasdaq ticker symbol from MTBC to CCLD. CareCloud’s Series A Preferred Stock ticker will also change from MTBCP to CCLDP, and the Series B Preferred Stock ticker will change from MTBCO to CCLDO.

To arrange a meeting with CareCloud leadership, investors should contact CareCloud’s investor relations firm, ICR Westwicke, at This email address is being protected from spambots. You need JavaScript enabled to view it..

About CareCloud

CareCloud (Nasdaq: MTBC, MTBCP and MTBCO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. Approximately 40,000 providers count on CareCloud to help improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, telehealth and patient experience management (PXM) at www.carecloud.com.

For additional information, please visit our website at www.carecloud.com.

Follow CareCloud on LinkedInTwitter and Facebook.

For additional information, please visit our website at www.carecloud.com. To view CareCloud’s latest investor presentations, read recent press releases, and listen to interviews with management, please visit ir.carecloud.com.

Company Contact:
Bill Korn
Chief Financial Officer
CareCloud, Inc.
This email address is being protected from spambots. You need JavaScript enabled to view it.

Investor Contact:
Asher Dewhurst
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.

Media Inquiries:
Alexis Feinberg
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.

Recursion

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page